Sign In
Buy CMRX
$8.54
+0 (+0%)
At Close: Jul 18, 2025
Chimerix to Present at H.C. Wainwright Virtual Fireside Chat Series
12:00pm, Thursday, 18'th Jun 2020
Chimerix (CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases, today announced that Company management, including Mike S
COVID-19 Therapeutics: The Leading Contenders
04:03am, Thursday, 04'th Jun 2020
While there is a huge interest in Covid-19 vaccine candidates, therapeutics are also an immediate need and will still be greatly in demand even after vaccines a
Chimerix to Present at Jefferies Virtual Healthcare Conference
12:00pm, Thursday, 28'th May 2020
Chimerix (CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases, today announced that Mike Sherman, Chief Executive Office
Revenue Downgrade: Here's What Analysts Forecast For Chimerix, Inc. (NASDAQ:CMRX)
10:47am, Tuesday, 12'th May 2020
The analysts covering Chimerix, Inc. (NASDAQ:CMRX) delivered a dose of negativity to shareholders today, by making a...
Chimerix (CMRX) Reports Q1 Loss, Lags Revenue Estimates
02:25pm, Thursday, 07'th May 2020
Chimerix (CMRX) delivered earnings and revenue surprises of -13.33% and -17.27%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Recap: Chimerix Q1 Earnings
01:07pm, Thursday, 07'th May 2020
Shares of Chimerix (NASDAQ:CMRX) were unchanged at $2.52 after the company reported Q1 results.Quarterly Results Earnings per share rose 51.43% over the past year to ($0.17), which missed the estimate
Chimerix Reports First Quarter 2020 Financial Results and Provides Operational Update
11:00am, Thursday, 07'th May 2020
DURHAM, N.C., May 07, 2020 -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious.
ADMA Biologics, Inc. (ADMA) CEO Adam Grossman on Q1 2020 Results - Earnings Call Transcript
02:32am, Thursday, 07'th May 2020
Start Time: 16:30 End Time: 17:13 ADMA Biologics, Inc. (NASDAQ:ADMA) Q1 2020 Earnings Conference Call May 06, 2020, 16:30 PM ET Company Participants Adam Grossm
One Thing To Remember About The Chimerix, Inc. (NASDAQ:CMRX) Share Price
12:40pm, Saturday, 02'nd May 2020
If you're interested in Chimerix, Inc. (NASDAQ:CMRX), then you might want to consider its beta (a measure of share...
82 Stocks Moving In Wednesday's Mid-Day Session
04:50pm, Wednesday, 29'th Apr 2020
Gainers
Capricor Therapeutics, Inc. (NASDAQ: CAPR) shares climbed 138.2% to $5.74 after the company reported that its new data from study of 6 critically-ill coronavirus patients...
Fly Intel: Pre-market Movers GILD;CMRX;BA;MA;HUM;EAT;DIN;GOOG;GOOGL;NOC;GE;GD;HAS;LH;APRN;F;PLYA
01:35pm, Wednesday, 29'th Apr 2020
Fly Intel: Pre-market Movers GILD CMRX BA MA HUM EAT DIN GOOG GOOGL NOC GE GD HAS LH APRN F PLYA
GOOGL, CHK among premarket gainers
01:21pm, Wednesday, 29'th Apr 2020
Spark Networks SE (NYSEMKT:LOV) +38% on 2H results.Chimerix (NASDAQ:CMRX) +29% on launch of DSTAT study in COVID-19.resTORbio (NASDAQ:TORC) +24% on merger with Adicet BioR. R. Donnelley & Sons (NY
The Daily Biotech Pulse: Inovio's MERS Vaccine Data, Fast Track Designation For Erytech, FDA Approves Higher Dose Of Merck's Keytruda
12:40pm, Wednesday, 29'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs April 28.) * AstraZeneca plc (NYSE: AZN) * Arcturus Therapeu
16 Healthcare Stocks Moving In Wednesday's Pre-Market Session
11:35am, Wednesday, 29'th Apr 2020
Gainers
• Chimerix, Inc. (NASDAQ:CMRX) shares increased by 38.41% to $2.09 during Wednesday's pre-market session.
• Accuray, Inc. (NASDAQ:ARAY) shares increased by...
